PAC · CT · C00420398

Boehringer Ingelheim USA Corporation Political Action Committee (Boehringer PAC)

A traditional political action committee. It raises limited contributions and can give directly to candidates. Lobbyist/registrant PAC.

First filed Feb. 27, 2006. Treasurer: Dorota Biernat. Connected organization: Boehringer Ingelheim USA Corporation. View on FEC.gov (opens in a new tab)

  • Raised (2025-26)
    $285,047
  • Spent
    $276,420
  • Cash on hand
    $39,559
  • Outside spending
    $0

Raised, spent and cash on hand through reports covering Oct. 14, 2026.

Where its money went

  • Given: the group’s own contributions to the campaign
  • Bundled: donors’ contributions the group collected and forwarded
  • For: outside spending supporting
  • Against: outside spending opposing
    • Given$10K
    • Given$10K
    • Given$7K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$5K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$4K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K
    • Given$3K

Showing the top 20 of 83 candidates.

Bundled contributions (money donors route through a PAC to specific candidates) are broken out only for groups on our issue pages.

Money to parties and other committees

Who funds it

Largest single contributions this cycle. Committees and organizations link to their own pages when they file with the FEC; an organization that doesn’t file won’t show its own donors here.

Largest contributions received this cycle
ContributorTypeFromDateAmount
Katharine BondFederal Government Affairs Us_ed, Boehringer Ingelheim USA CorpPersonRidgefield, CTJan. 22, 2026$1,500 (opens in a new tab)
Daniel GuiniperoUS Asset Lead & Marketing Lead Us_vp, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTJuly 10, 2025$500 (opens in a new tab)
Daniel GuiniperoUS Asset Lead & Marketing Lead Us_vp, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTJune 17, 2026$500 (opens in a new tab)
Scott KingMarketing Livestock Us_ed, Boehringer Ingelheim Animal Health USAPersonJohns Creek, GASept. 23, 2026$250 (opens in a new tab)
William Davis Jr.Govt Affairs Animal Healt Us_director, Boehringer Ingelheim Animal Health USAPersonDuluth, GASept. 30, 2025$208 (opens in a new tab)
Jean-Michel BoersUs_10141_country Managing Director, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2025$208 (opens in a new tab)
Robert AndersonCorporate Affairs Us_vp, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2025$208 (opens in a new tab)
Craig WaughPayor Solutions Marketing Us_dir, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 30, 2025$208 (opens in a new tab)
Jamie Martin EdenUs_expat - Strategic HRBP - Human Phar, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2025$208 (opens in a new tab)
Jamie Martin EdenUs_expat - Strategic HRBP - Human Phar, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2025$208 (opens in a new tab)
Craig WaughPayor Solutions Marketing Us_dir, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 15, 2025$208 (opens in a new tab)
Robert AndersonCorporate Affairs Us_vp, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2025$208 (opens in a new tab)
Jean-Michel BoersUs_10141_country Managing Director, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2025$208 (opens in a new tab)
William Davis Jr.Govt Affairs Animal Healt Us_director, Boehringer Ingelheim Animal Health USAPersonDuluth, GASept. 15, 2025$208 (opens in a new tab)
Jamie Martin EdenUs_expat - Strategic HRBP - Human Phar, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2026$208 (opens in a new tab)
Brian HilberdinkUs_10141_head of Human Pharma, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 30, 2026$208 (opens in a new tab)
Christine BloomquistUs_32543_head Corporate Affairs US, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2026$208 (opens in a new tab)
Neeraja BalachanderUs_21023_head of Clinical Operations, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 30, 2026$208 (opens in a new tab)
Jean-Michel BoersUs_10141_country Managing Director, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 30, 2026$208 (opens in a new tab)
Jean-Michel BoersUs_10141_country Managing Director, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2026$208 (opens in a new tab)
Neeraja BalachanderUs_21023_head of Clinical Operations, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 15, 2026$208 (opens in a new tab)
Christine BloomquistUs_32543_head Corporate Affairs US, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2026$208 (opens in a new tab)
Brian HilberdinkUs_10141_head of Human Pharma, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTSept. 15, 2026$208 (opens in a new tab)
Jamie Martin EdenUs_expat - Strategic HRBP - Human Phar, Boehringer Ingelheim USA CorpPersonRidgefield, CTSept. 15, 2026$208 (opens in a new tab)
Brian HilberdinkUs_10141_head of Human Pharma, I Boehringer Ingelheim PharmaceuticalsPersonRidgefield, CTAug. 31, 2026$208 (opens in a new tab)

See every contribution to Boehringer Ingelheim USA Corporation Political Action Committee (Boehringer PAC) on FEC.gov (opens in a new tab). Contributions of $200 or less aren’t listed by name.